The atherosclerosis–cancer axis: the shared immunotherapeutic potential of CBL inhibition

Kai-Uwe Jarr

Author

Lingfeng Luo

Author

Nicholas J Leeper

Author

Stanford University School of Medicine Palo Alto , United States of America